Magnitude of opportunistic infections and associated factors among HIV-infected individuals attending care and treatment clinics in Dar es Salaam, Tanzania: a hospital-based cross-sectional study

被引:0
|
作者
Njelekela, Doris Andrew [1 ,2 ]
Kishimba, Rogath [3 ]
Noah, Mololo [3 ]
Kamori, Doreen [2 ,4 ]
Majigo, Mtebe [2 ]
Joachim, Agricola [2 ]
机构
[1] Muhimbili Natl Hosp, Microbiol, Dar Es Salaam, Tanzania
[2] Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania
[3] Tanzania Field Epidemiol & Lab Training Programme, Dar Es Salaam, Tanzania
[4] Kumamoto Univ, Joint Res Ctr Human Retrovirus Infect, Kumamoto, Kumamoto, Japan
来源
BMJ OPEN | 2025年 / 15卷 / 01期
关键词
HIV & AIDS; INFECTIOUS DISEASES; Diagnostic microbiology; MICROBIOLOGY; ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY; MIDDLE; IMPACT;
D O I
10.1136/bmjopen-2024-085725
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives This study aims to assess the magnitude of opportunistic infection (OI) and to identify factors associated with OIs among people living with HIV (PLHIV) on antiretroviral treatment (ART), attending HIV care and treatment clinics. Design A hospital-based cross-sectional study. Setting The study was conducted at Muhimbili National Hospital, Mwananyamala and Temeke Regional Referral Hospitals, in Dar es Salaam, Tanzania. Participants We enrolled 382 PLHIV on ART who were attending HIV care and treatment clinics in Dar es Salaam. Structured questionnaires were used to collect socio-demographic information, and a checklist was used to extract clinical characteristics from the client's HIV care and treatment clinic cards. Information was subjected to descriptive and regression analysis using Stata V.13. All factors were considered significant at p<0.05. Primary outcome Magnitude, spectrum of OI and associated factors among PLHIV using ART. Results A total of 382 PLHIV on ART were randomly selected and recruited in the study. The overall prevalence of OIs was 25.13%; the leading OI was tuberculosis affecting 58 patients (15.2%). CD4+ T cell counts <= 200 cells/<mu>L (aOR=13.61; 95% CI: 6.09 to 30.38) p<0.001, isoniazid preventive treatment (IPT) (aOR=4.10; 95% CI: 1.97 to 8.53) p<0.001, WHO clinical stage 4 (aOR=6.37; 95% CI: 1.47 to 27.61) p=0.013, divorced individuals (aOR=3.57; 95% CI: 1.43 to 8.90) p=0.006, male (aOR=3.04; 95% CI: 1.50 to 6.17) p=0.007, haemoglobin level<11.0 g/dL (aOR=2.25; 95% CI: 1.14 to 4.47) p=0.020 and level of education of primary and below (aOR=4.31; 95% CI: 1.8 to 10.32) p=0.001 showed significant association with OIs. Conclusion There was still a high prevalence of OI observed in this study which needs to be addressed. CD4+ T cell counts of <= 200 cells/<mu>L, advanced WHO clinical stages, no use of IPT prophylaxis, anaemia and low education level were predictors of OIs. Promptly implementing the test-and-treat protocol while an individual's immunity is still strong and timely screening for OI are critical.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Factors associated with exclusive breast feeding among mothers in formal employment in Dar es Salaam, Tanzania: a cross-sectional study
    Mkono, Nsiah
    Chirande, Lulu
    Moshiro, Robert
    Noorani, Mariam
    BMJ OPEN, 2024, 14 (11):
  • [22] Determinants of isoniazid preventive therapy completion among people living with HIV attending care and treatment clinics from 2013 to 2017 in Dar es Salaam Region, Tanzania. A cross-sectional analytical study
    Robert, Masanja
    Todd, Jim
    Ngowi, Bernard J.
    Msuya, Sia E.
    Ramadhani, Angella
    Sambu, Veryhel
    Jerry, Isaya
    Mujuni, Martin R.
    Mahande, Michael J.
    Ngocho, James S.
    Maokola, Werner
    BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [23] Determinants of isoniazid preventive therapy completion among people living with HIV attending care and treatment clinics from 2013 to 2017 in Dar es Salaam Region, Tanzania. A cross-sectional analytical study
    Masanja Robert
    Jim Todd
    Bernard J. Ngowi
    Sia E. Msuya
    Angella Ramadhani
    Veryhel Sambu
    Isaya Jerry
    Martin R. Mujuni
    Michael J. Mahande
    James S. Ngocho
    Werner Maokola
    BMC Infectious Diseases, 20
  • [24] Hepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar es Salaam, Tanzania
    Tumaini J Nagu
    Muhammad Bakari
    Mecky Matee
    BMC Public Health, 8
  • [25] Hepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar es Salaam, Tanzania
    Nagu, Tumaini J.
    Bakari, Muhammad
    Matee, Mecky
    BMC PUBLIC HEALTH, 2008, 8 (1)
  • [26] Seroprevalence of syphilis among HIV-infected individuals in Addis Ababa, Ethiopia: a hospital-based cross-sectional study
    Eticha, Begna Tulu
    Sisay, Zufan
    Alemayehu, Addisu
    Shimelis, Techalew
    BMJ OPEN, 2013, 3 (04):
  • [27] Precancerous Cervical Lesions Among HIV-Infected Women Attending HIV Care and Treatment Clinics in Southwest Ethiopia: A Cross-Sectional Study
    Lemu, Lidiya Gutema
    Woldu, Biruktawit Fekade
    Teke, Natnael Eshetu
    Bogale, Nardos Delelegn
    Wondimenew, Ermias Ayalew
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2021, 13 : 297 - 303
  • [28] Intimate partner violence among HIV-positive women in discordant relationships attending care and treatment clinics in Dar es Salaam, Tanzania
    Mathania, Milka
    Sirili, Nathanael
    FRONTIERS IN PUBLIC HEALTH, 2023, 10
  • [29] Clinical depression prevalence and associated factors among adolescents with sickle cell anemia in dar es salaam, tanzania: a cross-sectional study
    Athman, Linda Paul
    Jonathan, Agnes
    Musa, Fatima
    Kipasika, Honesta John
    Mahawi, Isihaka
    Urio, Florence
    Ally, Mwashungi
    Mutagonda, Ritah
    Chirande, Lulu
    Makani, Julie
    Balandya, Emmanuel
    BMC PEDIATRICS, 2025, 25 (01)
  • [30] The magnitude of opportunistic infections and associated factors in HIV-infected adults on antiretroviral therapy in southern zone Tigray, Ethiopia: a cross-sectional study
    Weldearegawi, Teklay Zeru
    Gerensea, Hadgu
    Berihu, Hagos
    Gidey, Gebreamlak
    Welearegay, Mebrahtom Zeru
    PAN AFRICAN MEDICAL JOURNAL, 2020, 35